JONATHON RUTT: Open Payments
NPI 1689343402 · LAVEEN, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 70 payments from 17 companies in 2025. Trend: 2023 $579 · 2024 $543 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $351 |
| Novo Nordisk Inc | 11 | $202 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Astellas Pharma US Inc | 3 | $68 |
| PFIZER INC. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $54 |
| TOLMAR, INC. | 2 | $36 |
| Renalytix AI, Inc. | 1 | $20 |
Products named: QULIPTA, VRAYLAR, Wegovy, Ozempic, Veozah, CAPLYTA, TRELEGY ELLIPTA, Kerendia.
Industry payments across AZ — which companies pay providers there.
